Insights

Leadership Change CEO departure in May 2025 opens doors for renewed outreach to strategic partners and potential licensing discussions, creating opportunities to sponsor genomics projects and accelerate clinical translation collaborations.

Partnership Momentum A history of collaborations with healthcare organizations and biotech firms suggests strong receptivity to joint R&D, data sharing, and service partnerships; target CROs, pharma, and biotech ecosystems for co-development and contract research opportunities.

Revenue Scale With a multi-billion revenue profile, deCODE can be a high-value prospect for enterprise data management, secure data exchange, and cloud-based genomics analytics; tailor licensing, hosting, and managed services proposals to large institutions.

Security Platform Existing security-minded tech stack (Cloudflare, OpenSSL) positions a need for compliant data platforms and SOC 2/ISO 27001 offerings, making a case for secure data sharing, governance, and scalable analytics solutions.

Market Positioning The competitive landscape favors partnerships around population genomics resources and translational biology; present differentiators such as large-scale genomic datasets, population diversity, and scalable platform capabilities to win data licensing and collaboration deals.

deCODE genetics Tech Stack

deCODE genetics uses 8 technology products and services including MySQL, jQuery, Red Hat, and more. Explore deCODE genetics's tech stack below.

  • MySQL
    Database
  • jQuery
    Javascript Libraries
  • Red Hat
    Operating Systems
  • PHP
    Programming Languages
  • Yoast SEO
    Search Engines
  • OpenSSL
    Web Server Extensions
  • FitVids.js
    Web Tools And Plugins
  • easy pie chart
    Web Tools And Plugins

Media & News

deCODE genetics's Email Address Formats

deCODE genetics uses at least 1 format(s):
deCODE genetics Email FormatsExamplePercentage
First.Last@decode.comJohn.Doe@decode.com
76%
FLast@decode.comJDoe@decode.com
11%
FirstL@decode.comJohnD@decode.com
9%
First@decode.comJohn@decode.com
4%

Frequently Asked Questions

What is deCODE genetics's phone number?

Minus sign iconPlus sign icon
You can contact deCODE genetics's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is deCODE genetics's stock symbol?

Minus sign iconPlus sign icon
deCODE genetics is a publicly traded company; the company's stock symbol is DCGNQ.

What is deCODE genetics's official website and social media links?

Minus sign iconPlus sign icon
deCODE genetics's official website is decode.com and has social profiles on LinkedInCrunchbase.

What is deCODE genetics's SIC code NAICS code?

Minus sign iconPlus sign icon
deCODE genetics's SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does deCODE genetics have currently?

Minus sign iconPlus sign icon
As of July 2026, deCODE genetics has approximately 188 employees across 6 continents, including EuropeSouth AmericaNorth America. Key team members include Chief Executive Officer: K. S.Vp Of Informatics: G. M.Vp Informatics: H. G.. Explore deCODE genetics's employee directory with LeadIQ.

What industry does deCODE genetics belong to?

Minus sign iconPlus sign icon
deCODE genetics operates in the Biotechnology Research industry.

What technology does deCODE genetics use?

Minus sign iconPlus sign icon
deCODE genetics's tech stack includes MySQLjQueryRed HatPHPYoast SEOOpenSSLFitVids.jseasy pie chart.

What is deCODE genetics's email format?

Minus sign iconPlus sign icon
deCODE genetics's email format typically follows the pattern of First.Last@decode.com. Find more deCODE genetics email formats with LeadIQ.

When was deCODE genetics founded?

Minus sign iconPlus sign icon
deCODE genetics was founded in 1996.

deCODE genetics

Biotechnology ResearchReykjavík-1, Iceland51-200 Employees

deCODE genetics operates in biotechnology research with a focus on decoding the human genome. Based in Reykjavik, Iceland, it leverages population resources and specialized expertise to identify genetic risk factors for a range of common diseases. Its work aims to translate these insights into new methods for diagnosing, treating, and preventing disease.

Recognized as a global leader in genome analysis, the company serves the broader biomedical research community seeking genetic insights to inform medical practice. In May 2025, Kári Stefánsson stepped down as CEO.

Section iconCompany Overview

Phone number
Website
decode.com
SIC Code
8731 - Commercial Physical and Biological Research
Stock Symbol
DCGNQ
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
1996
Employees
51-200

Section iconFunding & Financials

  • $1B$10B

    deCODE genetics's revenue is estimated to be in the range of $1B$10B

Section iconFunding & Financials

  • $1B$10B

    deCODE genetics's revenue is estimated to be in the range of $1B$10B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.